Total Lab Automation Market Size, Share & Trends Analysis Report By Application,(Diagnostics, Genomic Solutions, Microbiology, Drug Discovery, Proteomic Solutions and Other Applications) By End-User, By Region, And By Segment Forecasts, 2024-2031.
Segmentation of Total Lab Automation Market-
Total Lab Automation Market By Application-
- Diagnostics
- Genomic Solutions
- Microbiology
- Drug Discovery
- Proteomic Solutions
- Other Applications
Total Lab Automation Market By End-User-
- Pharmaceutical and Biotechnology Companies
- Research and Diagnostic Laboratories
- Other End-Users
Total Lab Automation Market By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Total Lab Automation Market Snapshot
Chapter 4. Global Total Lab Automation Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter’s Five Forces Analysis
4.6. Competitive Landscape & Market Share Analysis
4.7. Technology Advancement in Total Lab Automation Market
4.8. Key Trends in the Market
Chapter 5. Market Segmentation 1: Application Estimates & Trend Analysis
5.1. Application & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2024 to 2031 for the following Application:
5.2.1. Diagnostics
5.2.2. Genomic Solutions
5.2.3. Microbiology
5.2.4. Drug Discovery
5.2.5. Proteomic Solutions
5.2.6. Other Applications
Chapter 6. Market Segmentation 2: End-user Estimates & Trend Analysis
6.1. End-user & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2024 to 2031 for the following End-user:
6.2.1. Pharmaceutical and Biotechnology Companies
6.2.2. Research and Diagnostic Laboratories
6.2.3. Other End-Users
Chapter 7. Total Lab Automation Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Total Lab Automation Market revenue (US$ Million) estimates and forecasts by Application, 2024-2031
7.1.2. North America Total Lab Automation Market revenue (US$ Million) estimates and forecasts by End-user, 2024-2031
7.1.3. North America Total Lab Automation Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
7.1.3.1. U.S.
7.1.3.2. Canada
7.2. Europe
7.2.1. Europe Total Lab Automation Market revenue (US$ Million) estimates and forecasts by Application, 2024-2031
7.2.2. Europe Total Lab Automation Market revenue (US$ Million) estimates and forecasts by End-user, 2024-2031
7.2.3. Europe Total Lab Automation Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
7.2.3.1. Germany
7.2.3.2. France
7.2.3.3. Italy
7.2.3.4. Spain
7.2.3.5. UK
7.2.3.6. Rest of Europe
7.3. Asia Pacific
7.3.1. Asia Pacific Total Lab Automation Market revenue (US$ Million) estimates and forecasts by Application, 2024-2031
7.3.2. Asia Pacific Total Lab Automation Market revenue (US$ Million) estimates and forecasts by End-user, 2024-2031
7.3.3. Asia Pacific Total Lab Automation Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
7.3.3.1. China
7.3.3.2. India
7.3.3.3. Japan
7.3.3.4. Australia
7.3.3.5. Rest of Asia Pacific
7.4. Latin America
7.4.1. Latin America Total Lab Automation Market revenue (US$ Million) estimates and forecasts by Application, 2024-2031
7.4.2. Latin America Total Lab Automation Market revenue (US$ Million) estimates and forecasts by End-user, 2024-2031
7.4.3. Latin America Total Lab Automation Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
7.4.3.1. Brazil
7.4.3.2. Rest of Latin America
7.5. MEA
7.5.1. MEA Total Lab Automation Market revenue (US$ Million) estimates and forecasts by Application, 2024-2031
7.5.2. MEA Total Lab Automation Market revenue (US$ Million) estimates and forecasts by End-user, 2024-2031
7.5.3. MEA revenue Total Lab Automation Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
7.5.3.1. GCC Countries
7.5.3.2. South Africa
7.5.3.3. Rest of MEA
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Bionex Solutions
8.2.2. COPAN Diagnostics
8.2.3. ERWEKA
8.2.4. GeSim
8.2.5. MGI
8.2.6. Molecular Devices
8.2.7. Nova Biomedical
8.2.8. Pall Corporation
8.2.9. Thermo Fisher Scientific
8.2.10. Tecan Group
8.2.11. Danaher Corporation
8.2.12. Agilent Technologies
8.2.13. F. Hoffmann-La Roche
8.2.14. Perkinelmer
8.2.15. Eppendorf
8.2.16. Becton, Dickinson And Company
8.2.17. Waters Corporation
8.2.18. Siemens Healthineers
8.2.19. Abbott Laboratories
8.2.20. bioMérieux
8.2.21. Endress+Hauser Group
8.2.22. Hamilton Company
8.2.23. Hudson Robotics
8.2.24. Gilson, Inc.
8.2.25. BMG Labtech
8.2.26. Aurora Biomed Inc.
8.2.27. Peak Analysis & Automation
8.2.28. Formulatrix
8.2.29. Qiagen N.V.
8.2.30. Labvantage Solutions, Inc.
8.2.31. Bio-Rad Laboratories, Inc.
8.2.32. Labware
8.2.33. Analytik Jena GMBH
8.2.34. Other Prominent Player
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Total Lab Automation Market Size is valued at USD 508.9 Mn in 2023 and is predicted to reach USD 1,256.1 Mn by the year 2031
Total Lab Automation Market is expected to grow at a 12.1% CAGR during the forecast period for 2024-2031.
Gilson, Inc., BMG Labtech, Aurora Biomed Inc., Peak Analysis & Automation, Formulatrix, Qiagen N.V., Labvantage Solutions, Inc., Bio-Rad Laboratories,